Our latest work: As it turns out different positive allosteric modulators bind to different sites at the mu opioid receptor. Find out more in our @biorxivpreprint.
biorxiv.org/content/10.1101/…
A take on the current state of biased signaling in psychedelic action and psychedelic drug discovery by John McCorvy and I:
Biased Signaling in Psychedelic Action | Annual Reviews - go.shr.lc/4lx1pLf
Job Alert! Open Postdoc position in membrane protein structural biology, molecular pharmacology @ drug discovery in New York.
More info can be found here: wackerlab.com/
Lessons from a Toad Psychedelic about the Role of different Serotonin Receptors in Psychedelic Physiology: nature.com/articles/s41586-0…
Congrats to Audrey and @LankriDavidIL in this collab with @SamesLab and @ScottRusso published in @Nature
Asenapine as a potent TAAR1 agonist
nature.com/articles/s41467-0…
Congrats @NeuroStructure
Tetracyclic antidepressants potently activate serotonin receptors 5-HT1e and 5-HT1F, explaining some of their clinically observed effects. @NeuroStructure @martafilizola @biorxivpreprint @biorxiv_neursci
biorxiv.org/content/10.1101/…
Also, here is our @biorxivpreprint on the structure and pharmacological properties of human TAAR1
biorxiv.org/content/10.1101/…
Also, the lab is looking for a Postdoc conducting the type of research described in the paper: CryoEM, membrane protein function and pharmacology, drug discovery.
Structural Studies and Drug Discovery of SLC4A1/AE1 with @SchlessingerLab published in @NatureSMB: nature.com/articles/s41594-0…

